Founded
Address
Venrock Associates
55 Cambridge Parkway
Suite 100
Cambridge, MA 02142
United States
Venrock Associates
Palo Alto, CA 00000
United States
Phone
Website
Recent investment activity
KANDO id: 32106
Corporate information
Registration country
Company type
The venture capital arm of the Rockefeller Family.Funding rounds
Investment preferences
Minimum investment (USD)
2,000,000
Maximum initial investment (USD)
40,000,000
Investment size comment
USD 10 million sweet spot.
Stage focus
Investment activity status
Active investor
Selected investments
Displaying 126 - 150 of 283| Company | Profile | Country | Date Sort descending | Funding | ||
|---|---|---|---|---|---|---|
|
Athena Neurosciences Inc | Development of diagnostics and therapeutics for Alzheimer's Disease | N/A Initial investment | |||
![[current-page:title] logo](/sites/default/files/styles/icon/public/default_images/_no-logo.png?itok=AH4pbDYM){kind=icon}
|
American Superconductor Corp | N/A | ||||
|
|
Mitek Surgical Products Inc | N/A Initial investment | ||||
|
|
NovaCare Rehabilitation Inc | N/A Initial investment | ||||
|
Gilead Sciences Inc | A biopharmaceutical company that discovers, develops and commercializes therapeutics. | N/A Initial investment | |||
|
Ligand Pharmaceuticals Inc | N/A | ||||
|
|
PerSeptive Biosystems Inc | N/A Initial investment | ||||
|
|
Pharmacyclics Inc | N/A Initial investment | ||||
|
|
EP Technologies Inc | Medical device company providing electrophysiology catheters and systems. | N/A Initial investment | |||
|
|
HealthSouth Corp | Healthcare providers specializing in rehabilitation. | N/A Initial investment | |||
|
|
Sugen Inc | Biopharmaceutical company that discovered and developed small molecule drugs used for diseases such as cancer and diabetes. | N/A Initial investment | |||
|
|
Vical Inc | N/A Initial investment | ||||
|
|
Geron Corp | Therapeutic and diagnostic products company. | N/A Initial investment | |||
|
|
Signal Pharmaceuticals Inc | Integrated target and drug discovery company focused on identifying new classes of small molecule drugs. | N/A Initial investment | |||
|
|
Millennium Pharmaceuticals Inc | N/A Initial investment | ||||
|
|
Anadys Pharmaceuticals Inc | N/A | ||||
|
|
Med Partners Inc | N/A Initial investment | ||||
|
|
CardioThoracic Systems Inc | N/A Initial investment | ||||
|
|
Sonic Innovations Inc | N/A Initial investment | ||||
|
|
Triangle Pharmaceuticals Inc | Anti-viral and oncology licensing company. | N/A Initial investment | |||
|
|
Symyx Technologies | Develops and applies high-speed combinatorial technologies to the discovery of materials for life science, chemical, and electronics applications. | N/A Initial investment | |||
|
|
ORATEC Interventions Inc | N/A Initial investment | ||||
|
|
Caliper Life Sciences Inc | N/A Initial investment | ||||
|
|
Icagen Inc | Biopharmaceutical company developing small molecule therapeutics that target ion channels for treatment of a variety of diseases. | N/A Initial investment | |||
|
Illumina Inc | Developer, manufacturer, and marketer of life science tools and integrated systems for large-scale analysis of genetic variation and function. | N/A |